Nyxoah Reports Preliminary Q2 2026 Revenue of €7.7 Million

Key Facts

Reflecting the sustained growth within the advanced medical devices sector, Nyxoah has released its preliminary financial results for the second quarter of 2026. According to reports, the company achieved revenue of €7.7 million during this period. This early disclosure is intended to provide investors with a preliminary look at the firm's financial health ahead of the comprehensive quarterly earnings release.

This revenue growth arrives amid high competition in the sleep apnea technology market, as Nyxoah seeks to expand its market share against peers such as Inspire Medical Systems. Based on historical performance, the company has demonstrated an upward trend compared to previous fiscal periods, strengthening the case for its organic growth trajectory per market data.

Regarding macroeconomic catalysts, investors are monitoring Eurozone inflation data, which was recently reported at 2.8% (as of July 1, 2026), as borrowing costs may influence capital expenditure within the healthcare sector.